Akums Group

Akums Group company information, Employees & Contact Information

Explore related pages

Related company profiles:

The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe. The 9 state-of-the-art facilities are dedicated to Oral Solid Dosage forms (with separate units for Beta Lactum and Non-Beta Lactum formulations), Oral Liquid Dosage forms, Sterile Dosage forms (Injectable, eye, Ear & Nasal), Hormonal (Oral and Injectable), Ointments & Cosmetics, Ayurvedic, Food Supplements & Nutraceuticals.

Company Details

Employees
283
Founded
-
Address
Plot No. 26a-30, Sector 8a, Sidcul Iie, Haridwar, Sidcul,india
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Haridwar, Uttarakhand
Looking for a particular Akums Group employee's phone or email?

Akums Group Questions

News

Akums to establish pharmaceutical manufacturing facility in Zambia - BioSpectrum India

Akums to establish pharmaceutical manufacturing facility in Zambia BioSpectrum India

Akums Drugs & Pharma Hormonal manufacturing plant gets EAEU GMP Certification - Medical Dialogues

Akums Drugs & Pharma Hormonal manufacturing plant gets EAEU GMP Certification Medical Dialogues

Akums Partners With TNAU To Drive Pharma Innovation With Agri-Based Research - BW Healthcare World

Akums Partners With TNAU To Drive Pharma Innovation With Agri-Based Research BW Healthcare World

Tarun Kapoor to lead tech and digital affairs at Akums Drugs & Pharmaceuticals - Techcircle

Tarun Kapoor to lead tech and digital affairs at Akums Drugs & Pharmaceuticals Techcircle

Akums Drugs & Pharmaceuticals Installs 600 kWp Rooftop Solar Plant in its Haridwar Warehouse - Energetica India Magazine

Akums Drugs & Pharmaceuticals Installs 600 kWp Rooftop Solar Plant in its Haridwar Warehouse Energetica India Magazine

Akums Drugs Reports 12% EBITDA growth, secures €200M EU deal - Adgully.com

Akums Drugs Reports 12% EBITDA growth, secures €200M EU deal Adgully.com

Akums Drugs & Pharma appoints Tarun Kapoor as CIO - Medical Dialogues

Akums Drugs & Pharma appoints Tarun Kapoor as CIO Medical Dialogues

Quadria partially exits Akums Drugs via IPO - The Asset

Quadria partially exits Akums Drugs via IPO The Asset

Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness - Indian Pharma Post

Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness Indian Pharma Post

Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI Approvals - Tribune India

Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI Approvals Tribune India

Akums Drugs Gets Buy From Citi As Brokerage Initiates Coverage—Heres Why - NDTV Profit

Akums Drugs Gets Buy From Citi As Brokerage Initiates Coverage—Heres Why NDTV Profit

Akums to set up new manufacturing plant in Zambia via JV with local govt - ET Pharma

Akums to set up new manufacturing plant in Zambia via JV with local govt ET Pharma

Akums Drugs and Pharmaceuticals IPO listing tomorrow: Here’s what GMP, subscription status hint ahead of listing - Mint

Akums Drugs and Pharmaceuticals IPO listing tomorrow: Here’s what GMP, subscription status hint ahead of listing Mint

CDSCO Panel Asks Akums for Detailed Data on Phase III Eye Drop Trial - Medical Dialogues

CDSCO Panel Asks Akums for Detailed Data on Phase III Eye Drop Trial Medical Dialogues

Akums Drugs IPO listing date today. What GMP, experts signal on expected listing price - Mint

Akums Drugs IPO listing date today. What GMP, experts signal on expected listing price Mint

Akums Reports Q4 Revenue Growth Of 12.4%, Focuses On Global Expansion - BW Healthcare World

Akums Reports Q4 Revenue Growth Of 12.4%, Focuses On Global Expansion BW Healthcare World

Akums Drugs share price makes a lukewarm debut, stock opens with a mere 7% premium at ₹725 apiece on NSE - Mint

Akums Drugs share price makes a lukewarm debut, stock opens with a mere 7% premium at ₹725 apiece on NSE Mint

Akums Drugs IPO closes tomorrow: Check out 10 key things to know from RHP before investing - Mint

Akums Drugs IPO closes tomorrow: Check out 10 key things to know from RHP before investing Mint

Akums Drugs IPO subscribed 4.43 times on the second day of bidding, retail investors steal the show; check GMP - Mint

Akums Drugs IPO subscribed 4.43 times on the second day of bidding, retail investors steal the show; check GMP Mint

Akums Drugs IPO opens tomorrow: GMP, issue details, 10 key things to know - Mint

Akums Drugs IPO opens tomorrow: GMP, issue details, 10 key things to know Mint

Akums Drugs and Pharma: Jitendra Mishra steps down as Senior Vice President - IT - Medical Dialogues

Akums Drugs and Pharma: Jitendra Mishra steps down as Senior Vice President - IT Medical Dialogues

Akums Drugs IPO: 10 key risks investors should know before investing to the issue - Mint

Akums Drugs IPO: 10 key risks investors should know before investing to the issue Mint

U.K. drug regulatory agency orders Akums to recall batches of progesterone - Fierce Pharma

U.K. drug regulatory agency orders Akums to recall batches of progesterone Fierce Pharma

Akums Pharma earns EAEU GMP approval for oral hormonal tablets - Healthcare Radius

Akums Pharma earns EAEU GMP approval for oral hormonal tablets Healthcare Radius

No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol,... - Medical Dialogues

No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol,... Medical Dialogues

Akums reports Q1 FY26 PAT at Rs. 65 Cr - Indian Pharma Post

Akums reports Q1 FY26 PAT at Rs. 65 Cr Indian Pharma Post

Akums Drugs IPO: Latest GMP, subscription status, review, other details. Apply or not? - Mint

Akums Drugs IPO: Latest GMP, subscription status, review, other details. Apply or not? Mint

Akums opens new facility for lyophilised and sterile dosage manufacturing - financialexpress.com

Akums opens new facility for lyophilised and sterile dosage manufacturing financialexpress.com

Akums launches sickle cell anaemia drug for 1% of global price - The Indian Express

Akums launches sickle cell anaemia drug for 1% of global price The Indian Express

Akums announces new facility for lyophilized, sterile dosage manufacturing - Business Standard

Akums announces new facility for lyophilized, sterile dosage manufacturing Business Standard

PLI scheme good, but more needs to be done to boost API research - The Hans India

PLI scheme good, but more needs to be done to boost API research The Hans India

The Driving Force Behind Akums Drugs and Pharmaceuticals - Times Now

The Driving Force Behind Akums Drugs and Pharmaceuticals Times Now

Akums partners with Leiutis and Biophore India to strengthen R&D in multiple therapies - financialexpress.com

Akums partners with Leiutis and Biophore India to strengthen R&D in multiple therapies financialexpress.com

Akums appoints Shantanu R Chobhe as Corporate Quality Assurance Head - BioSpectrum India

Akums appoints Shantanu R Chobhe as Corporate Quality Assurance Head BioSpectrum India

Akums' Hormonal Plant receives EAEU GMP certification - Express Pharma

Akums' Hormonal Plant receives EAEU GMP certification Express Pharma

Akums appoints Amrut Medhekar as CEO of its CDMO business - ET Pharma

Akums appoints Amrut Medhekar as CEO of its CDMO business ET Pharma

Akums develops indigenous Hydroxyurea oral suspension to prevent sickle cell disease at 1 pc cost of global .. - ET HealthWorld

Akums develops indigenous Hydroxyurea oral suspension to prevent sickle cell disease at 1 pc cost of global .. ET HealthWorld

Akums to partner with Leiutis, Biophore - Healthcare Radius

Akums to partner with Leiutis, Biophore Healthcare Radius

Buy Akums Drugs and Pharmaceuticals; target of Rs 710: ICICI Securities - Moneycontrol

Buy Akums Drugs and Pharmaceuticals; target of Rs 710: ICICI Securities Moneycontrol

Akums Drugs IPO allotment status out. What GMP signals as focus shifts to listing date - Mint

Akums Drugs IPO allotment status out. What GMP signals as focus shifts to listing date Mint

Pharma stock jumps after signing MoU with Government of Republic of Zambia - Trade Brains

Pharma stock jumps after signing MoU with Government of Republic of Zambia Trade Brains

Akums launches state-of-the-art lyophilized drug manufacturing facility - Healthcare Radius

Akums launches state-of-the-art lyophilized drug manufacturing facility Healthcare Radius

GSK notice to Akums, associate on alleged trademark infringement on its Ranitidine brand Zinetac - Medical Dialogues

GSK notice to Akums, associate on alleged trademark infringement on its Ranitidine brand Zinetac Medical Dialogues

Akums, India’s largest domestic-focused CDMO player, is all set to tap the capital market - ET HealthWorld

Akums, India’s largest domestic-focused CDMO player, is all set to tap the capital market ET HealthWorld

Akum Drugs Gets CDSCO Panel Nod To Conduct Post Marketing Surveillance study of Linezolid Sustained... - Medical Dialogues

Akum Drugs Gets CDSCO Panel Nod To Conduct Post Marketing Surveillance study of Linezolid Sustained... Medical Dialogues

UAE’s ADIA invests in India’s Akums Drugs and Pharma - ZAWYA

UAE’s ADIA invests in India’s Akums Drugs and Pharma ZAWYA

India Develops First Indigenous Hydroxyurea Oral Suspension To Combat Sickle Cell Disease At 1 Per cent Cost Of Global Price - NDTV

India Develops First Indigenous Hydroxyurea Oral Suspension To Combat Sickle Cell Disease At 1 Per cent Cost Of Global Price NDTV

Akums chalks out expansion plan as it eyes Rs 10,000 cr turnover by 2028 - Business Standard

Akums chalks out expansion plan as it eyes Rs 10,000 cr turnover by 2028 Business Standard

Adani Group, Piramal Healthcare, Akums in race to buy central government’s HLL Lifecare - Moneycontrol

Adani Group, Piramal Healthcare, Akums in race to buy central government’s HLL Lifecare Moneycontrol

Akums Drugs & Pharmaceuticals bags prestigious Business Excellence Award 2021 - ThePrint

Akums Drugs & Pharmaceuticals bags prestigious Business Excellence Award 2021 ThePrint

Akums Drugs & Pharmaceuticals bags India Pharma Award 2021 - Business Standard

Akums Drugs & Pharmaceuticals bags India Pharma Award 2021 Business Standard

News On Click - Global Prime News

News On Click Global Prime News

Arvind Srivastava joins Akums Drugs & Pharmaceuticals as President - HR - ETHRWorld.com

Arvind Srivastava joins Akums Drugs & Pharmaceuticals as President - HR ETHRWorld.com

Akums partners with Lyrus for patented drugs, formulations - Healthcare Radius

Akums partners with Lyrus for patented drugs, formulations Healthcare Radius

Akums Drugs & Pharmaceuticals forays into gummies segment, sets up manufacturing plant - Moneycontrol

Akums Drugs & Pharmaceuticals forays into gummies segment, sets up manufacturing plant Moneycontrol

Akums introduces DCGI approved FDC medication - Express Pharma

Akums introduces DCGI approved FDC medication Express Pharma

Akums acquires new formulation facility in Baddi, Himachal Pradesh - ET HealthWorld

Akums acquires new formulation facility in Baddi, Himachal Pradesh ET HealthWorld

Akums Drugs appoints Amrut Medhekar as CEO Of CDMO Business - MarcaMoney

Akums Drugs appoints Amrut Medhekar as CEO Of CDMO Business MarcaMoney

Akums reports Q4 FY25 with 12.4 per cent revenue growth at Rs 1,073 Cr - IndiaMedToday

Akums reports Q4 FY25 with 12.4 per cent revenue growth at Rs 1,073 Cr IndiaMedToday

Q4 Results Highlights 26 May: Snowman Logistics Q4 profit up, Sundaram Finance Q4 profit at ₹553 cr, Rategain Q4 profit at ₹55 cr, GIC, Sumitomo, KEC International, Brainbees, Blue Dart, Akums Drugs, Lyka Labs to announce Q4 results today, Gillette shar - BusinessLine

Q4 Results Highlights 26 May: Snowman Logistics Q4 profit up, Sundaram Finance Q4 profit at ₹553 cr, Rategain Q4 profit at ₹55 cr, GIC, Sumitomo, KEC International, Brainbees, Blue Dart, Akums Drugs, Lyka Labs to announce Q4 results today, Gillette shar BusinessLine

Akums Drugs IPO Date, Review, Price, Allotment Details - IPO Watch

Akums Drugs IPO Date, Review, Price, Allotment Details IPO Watch

CDSCO panel grants approval to Akums for PK study of pulmonary FDC - Medical Dialogues

CDSCO panel grants approval to Akums for PK study of pulmonary FDC Medical Dialogues

Akums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III Protocol - Medical Dialogues

Akums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III Protocol Medical Dialogues

Akums awards digital mandate to V Spark Communications - Exchange4Media

Akums awards digital mandate to V Spark Communications Exchange4Media

Giants of tomorrow: Akums Drugs & Pharmaceuticals - Business Today

Giants of tomorrow: Akums Drugs & Pharmaceuticals Business Today

AKUMS signs digital mandate with V Spark Communications - Adgully.com

AKUMS signs digital mandate with V Spark Communications Adgully.com

Akums Drugs & Pharmaceuticals Share Price Target 2025, 2026, 2030, 2040, 2050 - shareprice-target.com

Akums Drugs & Pharmaceuticals Share Price Target 2025, 2026, 2030, 2040, 2050 shareprice-target.com

Top Akums Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant